z-logo
open-access-imgOpen Access
Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis
Author(s) -
Steven M. Rowe,
Sonya L. Heltshe,
Tanja Gonska,
Scott H. Donaldson,
Drucy Borowitz,
Daniel Gelfond,
Scott D. Sagel,
Umer Khan,
Nicole Mayer-Hamblett,
Jill M. Van Dalfsen,
Elizabeth Joseloff,
Bonnie W. Ramsey
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/6390-mp35
Subject(s) - ivacaftor , potentiator , cystic fibrosis , cystic fibrosis transmembrane conductance regulator , regulator , mechanism (biology) , medicine , conductance , chemistry , pharmacology , physics , biochemistry , gene , quantum mechanics , condensed matter physics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here